Dr. Bansal brings to Biosion over 30 years of experience including leading major alliances and partnerships with Merck, GSK, CSL-Behring, Genentech, Wyeth, Sanofi-Aventis, Abbvie, and Mayo Clinic. He led the integration of Phase 2-3 assets into Janssen, Millennium and Pfizer.

Before joining Biosion, Dr. Bansal led major alliances with Merck, GSK, Sanofi, Abbvie among others. . He gained drug development, project leadership, and alliance/integration leadership experience during his tenure at Johnson & Johnson (13 years), Takeda (5 years) and Pfizer/Wyeth (13 years). During his career, He led over 30 project teams for molecules that include mAbs and novel biologics.

Dr. Bansal holds a Ph.D. from St. John’s University in Pharmaceutics and a MBA from City University, New York. He has also taken strategic leadership courses at Harvard Business School and Wharton School of Business at University of Pennsylvania.